AlphaBet: A phase I/II trial evaluating the combination of radium-223 and [177Lu]Lu-PSMAI&T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要